U
ULTRAGENYX
NASDAQ: RARE (Ultragenyx Pharmaceutical Inc.)
Kemas kini terakhir: 2 hari lalu, 8:41PM21.34
-0.37 (-1.70%)
| Penutupan Terdahulu | 21.71 |
| Buka | 21.94 |
| Jumlah Dagangan | 2,542,744 |
| Purata Dagangan (3B) | 2,815,493 |
| Modal Pasaran | 2,062,079,744 |
| Harga / Jualan (P/S) | 3.35 |
| Harga / Buku (P/B) | 247.70 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2026 |
| Margin Keuntungan | -93.04% |
| Margin Operasi (TTM) | -102.62% |
| EPS Cair (TTM) | -5.83 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 28.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 588.24% |
| Nisbah Semasa (MRQ) | 2.40 |
| Aliran Tunai Operasi (OCF TTM) | -389.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -172.94 M |
| Pulangan Atas Aset (ROA TTM) | -24.51% |
| Pulangan Atas Ekuiti (ROE TTM) | -377.06% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Ultragenyx Pharmaceutical Inc. | Menurun | Menurun |
AISkor Stockmoo
1.7
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | 1.0 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.70 |
|
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.20% |
| % Dimiliki oleh Institusi | 99.43% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sands Capital Management, Llc | 31 Dec 2025 | 3,485,724 |
| Rtw Investments, Lp | 31 Dec 2025 | 3,000,139 |
| Baker Bros. Advisors Lp | 31 Dec 2025 | 2,772,692 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 79.00 (Canaccord Genuity, 270.20%) | Beli |
| Median | 51.00 (138.99%) | |
| Rendah | 25.00 (Wedbush, 17.15%) | Pegang |
| Purata | 52.30 (145.08%) | |
| Jumlah | 9 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 21.91 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 18 Feb 2026 | 79.00 (270.20%) | Beli | 20.45 |
| Evercore ISI Group | 18 Feb 2026 | 34.00 (59.33%) | Beli | 20.45 |
| 17 Feb 2026 | 37.00 (73.38%) | Beli | 20.18 | |
| HC Wainwright & Co. | 17 Feb 2026 | 50.00 (134.30%) | Beli | 20.18 |
| 03 Feb 2026 | 60.00 (181.16%) | Beli | 24.80 | |
| Wedbush | 17 Feb 2026 | 25.00 (17.15%) | Pegang | 20.18 |
| Guggenheim | 05 Jan 2026 | 52.00 (143.67%) | Beli | 23.11 |
| B of A Securities | 02 Jan 2026 | 58.00 (171.79%) | Beli | 23.60 |
| Baird | 30 Dec 2025 | 47.00 (120.24%) | Beli | 22.78 |
| Jefferies | 30 Dec 2025 | 63.00 (195.22%) | Beli | 22.78 |
| Leerink Partners | 30 Dec 2025 | 70.00 (228.02%) | Beli | 22.78 |
| Wells Fargo | 30 Dec 2025 | 45.00 (110.87%) | Beli | 22.78 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CROMBEZ ERIC | - | 23.02 | -7,029 | -161,808 |
| HARRIS ERIK | - | 23.02 | -10,539 | -242,608 |
| HORN HOWARD | - | 22.55 | -10,044 | -229,660 |
| HUANG DENNIS KARL | - | 23.02 | -999 | -22,997 |
| HUIZENGA THEODORE ALAN | - | 23.02 | -1,780 | -40,976 |
| KAKKIS EMIL D | - | 23.02 | -54,404 | -1,252,380 |
| PARSCHAUER KARAH HERDMAN | - | 22.37 | -17,661 | -395,273 |
| PINION JOHN RICHARD | - | 23.02 | -10,029 | -230,868 |
| Jumlah Keseluruhan Kuantiti Bersih | -112,485 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,576,568 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 22.78 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| PARSCHAUER KARAH HERDMAN | Pegawai | 10 Mar 2026 | Jual (-) | 3,508 | 22.84 | 80,123 |
| PARSCHAUER KARAH HERDMAN | Pegawai | 06 Mar 2026 | Jual (-) | 6,018 | 21.25 | 127,883 |
| HORN HOWARD | Pegawai | 03 Mar 2026 | Jual (-) | 1,635 | 22.07 | 36,084 |
| HUANG DENNIS KARL | Pegawai | 02 Mar 2026 | Dibuang (-) | 999 | 23.02 | 22,997 |
| CROMBEZ ERIC | Pegawai | 02 Mar 2026 | Jual (-) | 7,029 | 23.02 | 161,808 |
| HORN HOWARD | Pegawai | 02 Mar 2026 | Jual (-) | 8,409 | 23.02 | 193,575 |
| HUIZENGA THEODORE ALAN | Pegawai | 02 Mar 2026 | Dibuang (-) | 148 | 23.02 | 3,407 |
| HUIZENGA THEODORE ALAN | Pegawai | 02 Mar 2026 | Jual (-) | 1,632 | 23.02 | 37,569 |
| PARSCHAUER KARAH HERDMAN | Pegawai | 02 Mar 2026 | Jual (-) | 8,135 | 23.02 | 187,268 |
| KAKKIS EMIL D | Pegawai | 02 Mar 2026 | Jual (-) | 54,404 | 23.02 | 1,252,380 |
| HARRIS ERIK | Pegawai | 02 Mar 2026 | Jual (-) | 10,539 | 23.02 | 242,608 |
| PINION JOHN RICHARD | Pegawai | 02 Mar 2026 | Jual (-) | 10,029 | 23.02 | 230,868 |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |